Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 3 papers. Top paper: “Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma”.
Brian Hess, Veronika Bachanová, Nancy L. Bartlett, Melissa M. Berrien-Elliott, Ethan McClain +21 more
Michael P. Rettig, Phil Powell, Kathryn O’Brien, David B. Clifford, Julie Ritchey +9 more
Cameron E. Williams, Caroline Mart, Jonathan Beall, Linda MacPherson, Joseph Azar +12 more